|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.39 USD | +2.21% |
|
+1.20% | -4.94% |
| Market Cap | 4.35B 3.82B 3.56B 3.27B 6.14B 417B 6.22B 42.29B 16.52B 206B 16.32B 15.97B 712B | P/E 2026 * |
64.6x | P/E 2027 * | 32.5x |
|---|---|---|---|---|---|
| Enterprise Value | 3.38B 2.97B 2.76B 2.54B 4.77B 324B 4.83B 32.86B 12.83B 160B 12.68B 12.41B 553B | EV / Sales 2026 * |
2.72x | EV / Sales 2027 * | 2.26x |
| Free-Float |
99.68% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: ACADIA Pharmaceuticals Inc.
| 1 day | +2.21% | ||
| 1 week | +1.20% | ||
| Current month | +0.36% | ||
| 1 month | +0.28% | ||
| 3 months | +13.86% | ||
| 6 months | -3.09% | ||
| Current year | -4.94% |
| 1 week | 24.23 |  | 25.78 |
| 1 month | 24.23 | | 26.51 |
| Current year | 19.89 | | 27.81 |
| 1 year | 19.69 | | 28.35 |
| 3 years | 13.4 | | 32.59 |
| 5 years | 12.24 | | 33.99 |
| 10 years | 12.24 | | 58.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
Catherine Adams
CEO | Chief Executive Officer | 55 | 20/09/2024 |
Mark Schneyer
DFI | Director of Finance/CFO | 52 | 10/09/2021 |
Scott Cenci
CTO | Chief Tech/Sci/R&D Officer | - | 04/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Laura Brege
BRD | Director/Board Member | 68 | 01/05/2008 |
Stephen Biggar
CHM | Chairman | 55 | 10/06/2016 |
Edmund Harrigan
BRD | Director/Board Member | 73 | 25/11/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/26/26 A | Sell | Controller/Auditor | -11,421 | 0.0067% | ||
| 5/29/26 A | Fiscal year | Director | 41,529 | 0.0243% | ||
| 5/29/26 A | Fiscal year | Director | 29,335 | 0.0171% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.21% | +1.20% | +9.20% | -12.51% | 4.35B | |
| +0.21% | -0.21% | -0.42% | +11.53% | 47.74B | |
| -0.61% | +4.26% | +396.16% | +647.20% | 39.98B | |
| 0.00% | +4.93% | +11.81% | +55.56% | 36.23B | |
| +2.48% | +4.57% | +7.05% | -5.05% | 35.59B | |
| +0.62% | +3.53% | +5.41% | +42.19% | 27.91B | |
| -2.00% | +11.64% | +31.71% | +136.81% | 16.45B | |
| -0.17% | +0.66% | - | - | 16.71B | |
| +0.39% | -3.62% | +2.63% | +7.73% | 13.21B | |
| +1.82% | +1.56% | -9.75% | -30.15% | 12.93B | |
| Average | +0.49% | +2.61% | +50.42% | +94.81% | 25.11B | |
| Weighted average by Cap. | +0.37% | +2.91% | +73.04% | +133.74% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.24B 1.09B 1.02B 933M 1.75B 119B 1.77B 12.08B 4.72B 58.79B 4.66B 4.56B 203B | 1.4B 1.23B 1.15B 1.05B 1.98B 134B 2B 13.62B 5.32B 66.32B 5.26B 5.14B 229B |
| Net income | 67.44M 59.28M 55.19M 50.68M 95.17M 6.47B 96.42M 656M 256M 3.19B 253M 248M 11.04B | 142M 125M 116M 107M 200M 13.61B 203M 1.38B 539M 6.72B 533M 521M 23.22B |
| Net Debt | -970M -853M -794M -729M -1.37B -93.01B -1.39B -9.43B -3.68B -45.93B -3.64B -3.56B -159B | -1.18B -1.04B -968M -889M -1.67B -113B -1.69B -11.51B -4.49B -56.02B -4.44B -4.35B -194B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/07/26 | $25.39 | +2.21% | 1,399,666 |
| 24/07/26 | $24.84 | +0.04% | 1,046,976 |
| 23/07/26 | $24.83 | -0.52% | 1,272,018 |
| 22/07/26 | $24.96 | -1.85% | 1,163,336 |
| 21/07/26 | $25.43 | +1.36% | 1,340,502 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACAD Stock
Select your edition
All financial news and data tailored to specific country editions
